George Mattheolabakis Selected Research

George Mattheolabakis Research Topics

Disease

24	Neoplasms (Cancer) 05/2023 - 02/2009
9	Lung Neoplasms (Lung Cancer) 05/2023 - 09/2013
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2014
2	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 04/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2015
2	Metaplasia 10/2017 - 07/2016
2	Carcinogenesis 07/2016 - 12/2014
2	Adenocarcinoma 04/2016 - 02/2009
2	Colonic Neoplasms (Colon Cancer) 10/2014 - 09/2013
1	Intestinal Diseases (Diseases, Intestinal) 07/2021
1	Inflammation (Inflammations) 11/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2018
1	Pancreatitis 07/2016
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 05/2016
1	Autoimmune Diseases (Autoimmune Disease) 09/2015
1	Experimental Arthritis 06/2013
1	Osteitis 06/2013
1	Arthritis (Polyarthritis) 06/2013
1	Skin Neoplasms (Skin Cancer) 10/2012
1	Melanoma (Melanoma, Malignant) 10/2012

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2015
4	Sulindac (Copal)FDA LinkGeneric 05/2015 - 10/2012
3	Nucleic AcidsIBA 07/2021 - 07/2018
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2009
3	2-(4-isobutylphenyl)propionic acid 4-(diethoxyphosphoryloxy)butyl esterIBA 12/2014 - 06/2012
2	Liposomes (Liposome)IBA 05/2023 - 06/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2023 - 09/2016
2	Epidermal Growth Factor (EGF)IBA 04/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 11/2019 - 07/2018
2	Ethylene Glycol (Monoethylene Glycol)IBA 12/2018 - 10/2017
2	CurcuminIBA 01/2018 - 09/2013
2	Valproic Acid (Depakote)FDA LinkGeneric 10/2017 - 01/2013
2	MicellesIBA 09/2016 - 09/2013
2	Ibuprofen (Motrin)FDA LinkGeneric 04/2016 - 12/2014
2	HydrogelsIBA 06/2013 - 10/2012
1	TrehaloseIBA 05/2023
1	Cytotoxins (Cytolysins)IBA 05/2023
1	LigandsIBA 05/2023
1	PeptidomimeticsIBA 05/2023
1	ChlorotoxinIBA 11/2022
1	Peptides (Polypeptides)IBA 11/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	compound 18IBA 01/2020
1	LuciferasesIBA 01/2020
1	PolymersIBA 08/2019
1	AcidsIBA 12/2018
1	Lipid NanoparticlesIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	poly(lactide) (polylactic acid)IBA 10/2017
1	poly(lactic acid-ethylene glycol)IBA 10/2017
1	SurvivinIBA 12/2016
1	Small Interfering RNA (siRNA)IBA 12/2016
1	PlatinumIBA 12/2016
1	Platinum Compounds (Compounds, Platinum)IBA 12/2016
1	LipidsIBA 12/2016
1	CeruletideIBA 07/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2016
1	AmidesIBA 04/2016
1	ErbB Receptors (EGF Receptor)IBA 04/2016
1	GelatinIBA 04/2016
1	Cyclin D1IBA 04/2016
1	Gemcitabine FDA Link 04/2016
1	DisulfidesIBA 04/2016
1	SolutionsIBA 04/2016
1	Glycerol (Glycerine)FDA LinkGeneric 04/2016
1	AntagomirsIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	RNA-Induced Silencing ComplexIBA 12/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2015
1	Hyaluronic Acid (Hyaluronan)IBA 01/2015
1	phospho-ibuprofen amideIBA 12/2014
1	EsterasesIBA 10/2014
1	Carboxylic Ester HydrolasesIBA 10/2014
1	EstersIBA 10/2014
1	Drug CombinationsIBA 09/2013
1	Freund's AdjuvantIBA 06/2013
1	Interleukin-6 (Interleukin 6)IBA 06/2013
1	Interleukin-10 (Interleukin 10)IBA 06/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2013
1	Poloxamer (Poloxamer 407)IBA 06/2013
1	Cimetidine (Biomet)FDA LinkGeneric 01/2013
1	AntigensIBA 10/2012
1	monomethoxypolyethylene glycol (MPEG)IBA 02/2009

Therapy/Procedure

9	Therapeutics 07/2021 - 10/2012
2	Drug Therapy (Chemotherapy) 05/2023 - 10/2012
1	Intralesional Injections 08/2019
1	Injections 07/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2016
1	Immunotherapy 09/2015
1	Intravenous Administration 10/2014
1	Oral Administration 06/2013